Trending
Uterine Transplantation- Hope For Infertile Women Desiring Pregnancy
Normal-Tension Glaucoma Closely Associated With Cognitive Deficits: BMJ
Air Pollution Tied To Increased Risk Of Premature Death In Patients With Heart Failure
Follow Us:
April 21, 2025

Get In Touch

Fecal Immunochemical Test Screening May Predict Long-Term Survival In Colorectal Cancer Laboratory Medicine

Fecal Immunochemical Test Screening May Predict Long-Term Survival In Colorectal Cancer

  • 18 February 2025
  • 2 months ago

Omeprazole Leads To Erectile Dysfunction In Healthy Young Adult:Case Study Urology

Omeprazole Leads To Erectile Dysfunction In Healthy Young Adult:Case Study

  • 18 February 2025
  • 2 months ago

Semaglutide Use In Adolescents Can Reduce Liver Enzymes Indicative Of Liver Damage: STEP TEENS Trial Analysis Gastroenterology

Semaglutide Use In Adolescents Can Reduce Liver Enzymes Indicative Of Liver Damage: STEP TEENS Trial Analysis

  • 18 February 2025
  • 2 months ago

GSK Gets USFDA Fast Track Designation For Bepirovirsen In Chronic Hepatitis B Gastroenterology

GSK Gets USFDA Fast Track Designation For Bepirovirsen In Chronic Hepatitis B

  • 18 February 2025
  • 2 months ago

Thiazolidinediones May Significantly Reduce Risk Of NAFLD, Finds Study Gastroenterology

Thiazolidinediones May Significantly Reduce Risk Of NAFLD, Finds Study

  • 18 February 2025
  • 2 months ago

Hydroxychloroquine May Reduce NAFLD Risk In Patients With Rheumatoid Arthritis Gastroenterology

Hydroxychloroquine May Reduce NAFLD Risk In Patients With Rheumatoid Arthritis

  • 18 February 2025
  • 2 months ago

High-Dose Green Tea Extract Harmful For Liver Of People With Certain Genetic Variations Gastroenterology

High-Dose Green Tea Extract Harmful For Liver Of People With Certain Genetic Variations

  • 18 February 2025
  • 2 months ago

FDA Approves OLPRUVA For Patients Living With Urea Cycle Disorder Nephrology

FDA Approves OLPRUVA For Patients Living With Urea Cycle Disorder

  • 18 February 2025
  • 2 months ago

Vedolizumab Effective For Inducing Remission In Patients With Chronic Pouchitis: Phase 4 Trial Surgery

Vedolizumab Effective For Inducing Remission In Patients With Chronic Pouchitis: Phase 4 Trial

  • 18 February 2025
  • 2 months ago

New Guideline For Low-Risk, Recurrent Abdominal Pain In Emergency Department Released Gastroenterology

New Guideline For Low-Risk, Recurrent Abdominal Pain In Emergency Department Released

  • 18 February 2025
  • 2 months ago

Hot Categories

Subscribe & Followers

Recent News
Obstretics-Gynaecology

Uterine Transplantation- Hope For Infertile Women...

  • 08 May, 2021
Ophthalmology

Normal-Tension Glaucoma Closely Associated With Co...

  • 10 October, 2022
Cardiology and CTVS

Air Pollution Tied To Increased Risk Of Premature...

  • 24 May, 2023

Daily Newsletter

Get all the top stories from Blogs to keep track.